![]() |
Volumn 88, Issue 2, 2008, Pages 89-91
|
Capreomycin
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMINOSALICYLIC ACID;
CAPREOMYCIN;
CAPREOMYCIN IA;
CAPREOMYCIN IB;
CAPREOMYCIN SULPHATE;
CISPLATIN;
COLISTIN;
CYCLOSERINE;
ETHAMBUTOL;
ETHIONAMIDE;
ISONIAZID;
KANAMYCIN;
METRONIDAZOLE;
RIFAMPICIN;
STREPTOMYCIN;
TUBERCULOSTATIC AGENT;
VANCOMYCIN;
ALKALOSIS;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
AREA UNDER THE CURVE;
BACTERICIDAL ACTIVITY;
CATARACT;
COLONY FORMING UNIT;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG POTENCY;
DRUG SAFETY;
DRUG SOLUBILITY;
DRUG STABILITY;
DRUG STRUCTURE;
DRUG TOLERABILITY;
DRUG URINE LEVEL;
EOSINOPHILIA;
HUMAN;
INJECTION SITE ABSCESS;
INJECTION SITE BLEEDING;
INJECTION SITE PAIN;
KIDNEY TUBULE DISORDER;
LEUKOCYTOSIS;
LEUKOPENIA;
MINIMUM INHIBITORY CONCENTRATION;
MOLECULAR WEIGHT;
MYCOBACTERIUM AVIUM;
MYCOBACTERIUM TUBERCULOSIS;
NEPHROTOXICITY;
NONHUMAN;
OTOTOXICITY;
PRIORITY JOURNAL;
RASH;
REVIEW;
RNA TRANSLATION;
SIDE EFFECT;
THROMBOCYTOPENIA;
TUBERCULOSIS;
UREA NITROGEN BLOOD LEVEL;
VESTIBULOCOCHLEAR NERVE DISEASE;
ANIMALS;
ANTITUBERCULAR AGENTS;
CAPREOMYCIN;
HUMANS;
MICE;
TREATMENT OUTCOME;
TUBERCULOSIS;
|
EID: 43249130149
PISSN: 14729792
EISSN: None
Source Type: Journal
DOI: 10.1016/S1472-9792(08)70004-0 Document Type: Review |
Times cited : (14)
|
References (9)
|